Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study (Q36844513)
scientific article published on April 2013
Language:
(P31) (Q13442814)
(P50) (Q67485110)
(Q111604424)
(P304) 1011-1021
(P433) 4
(P478) 65
(P577) Monday, April 1, 2013
(P921) (Q79460)
(Q188297)
(Q1485)
(Q422248)
(P1433) (Q4797636)
(P1476) "Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study" (language: en)
(P2093) Daniel J Wallace
Alberto Spindler
Vishala Chindalore
Eduardo Mysler
C Michael Neuwelt
Gabriel Robbie
Wendy I White
Brandon W Higgs
Yihong Yao
Liangwei Wang
Dominique Ethgen
Warren Greth
(P2860) (Q28304807)
(Q37835527)
(Q34177087)
(Q36856706)
(Q37773296)
(Q37730995)
(Q33743791)
(Q37511726)
(Q28246766)
(Q37478595)
(Q37236049)
(Q37125180)
(Q37304204)
(Q33284736)
(Q36761206)
(Q36743355)
(Q33369397)
(Q35555038)
(Q36370602)
(Q33973488)
(Q29614922)
(Q40974327)
(Q29547225)
(Q52884043)
(Q53495545)
(Q46851436)
(Q46557882)
(Q56774177)
(Q57316195)
(Q60699961)
(Q73065100)
(Q80152135)
(Q84626226)
(Q84614866)
(Q67974903)
other details
description scientific article published on April 2013

External Links